BridgeMD
Compares treatment options for Anxiolytic Effect
Official title Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery
ClinicalTrials.gov ID: NCT07050095
What this study is testing
What is Midazolam Group?
Midazolam Group is an investigational medicine, being studied as a potential treatment for anxiolytic effect.
Also referred to as Midazolam.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim is to investigate the anxiolytic effect, and hemodynamic stability of using virtual reality immersion in adult patients undergoing Dacryocystorhinostomy (DCR) operation under general anesthesia and to compare its effect to that of using Midazolam as a premedication.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Aged 18-65.
- Both sexes.
- American Society of Anesthesiologists (ASA) classification: I - II.
- Patient undergoing Dacryocystorhinostomy Surgery (DCR) operation under general anesthesia.
You likely can't join if
- Patient refusal.
- Patients with cardiac diseases.
- Patients with renal diseases.
- Patients with drug sensitivity and seizures.
- Substance abuse and addiction.
- Claustrophobia.
See the full eligibility criteria
- Aged 18-65.
- Both sexes.
- American Society of Anesthesiologists (ASA) classification: I - II.
- Patient undergoing Dacryocystorhinostomy Surgery (DCR) operation under general anesthesia.
- Patient refusal.
- Patients with cardiac diseases.
- Patients with renal diseases.
- Patients with drug sensitivity and seizures.
- Substance abuse and addiction.
- Claustrophobia.
- Patients with cerebrovascular disease.
- Psychiatric and cognitive disorder.
- Patients with severe teary eyes and blurring of vision.
- Patients who express discomfort during the test.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.